- Home
- XRTX vs SSY Comparison
XRTX vs SSY Comparison
Compare XRTX & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- SSY
- Stock Information
- Founded
- XRTX 2011
- SSY 1959
- Country
- XRTX Canada
- SSY United States
- Employees
- XRTX N/A
- SSY N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- SSY Hospital/Nursing Management
- Sector
- XRTX Health Care
- SSY Health Care
- Exchange
- XRTX Nasdaq
- SSY Nasdaq
- Market Cap
- XRTX 5.0M
- SSY 5.7M
- IPO Year
- XRTX N/A
- SSY N/A
- Fundamental
- Price
- XRTX $1.33
- SSY $0.80
- Analyst Decision
- XRTX Strong Buy
- SSY
- Analyst Count
- XRTX 1
- SSY 0
- Target Price
- XRTX $14.00
- SSY N/A
- AVG Volume (30 Days)
- XRTX 22.7K
- SSY 8.3K
- Earning Date
- XRTX 11-29-2024
- SSY 11-12-2024
- Dividend Yield
- XRTX N/A
- SSY N/A
- EPS Growth
- XRTX N/A
- SSY N/A
- EPS
- XRTX N/A
- SSY N/A
- Revenue
- XRTX N/A
- SSY $31,808,000.00
- Revenue This Year
- XRTX N/A
- SSY N/A
- Revenue Next Year
- XRTX N/A
- SSY N/A
- P/E Ratio
- XRTX N/A
- SSY N/A
- Revenue Growth
- XRTX N/A
- SSY N/A
- 52 Week Low
- XRTX $1.09
- SSY $0.53
- 52 Week High
- XRTX $7.00
- SSY $1.05
- Technical
- Relative Strength Index (RSI)
- XRTX 41.92
- SSY 45.98
- Support Level
- XRTX $1.29
- SSY $0.79
- Resistance Level
- XRTX $1.42
- SSY $0.86
- Average True Range (ATR)
- XRTX 0.15
- SSY 0.04
- MACD
- XRTX -0.01
- SSY -0.01
- Stochastic Oscillator
- XRTX 18.75
- SSY 8.75
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operates nearly 80-licensed-bed, acute care hospitals, which includes more than 18-bed geriatric psychology unit, and over 60-bed nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.